Login
Home
Charts
Search
Watchlist
Products

Sandu Pharmaceuticals Ltd

SANDUPHQ·BSE
₹37.76+0.91%Tue, 22 Sept '26
Industry:Pharma - Formulators
Indices:

Sandu Pharmaceuticals Ltd

SANDUPHQ
BSE
₹37.76
+0.91%
|Tue, 22 Sept '26
SOICxStockScans Reports
Industry
Pharma - Formulators
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹36Cr
Close
Close Price
₹37.76
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
19.27
PS
Price To Sales
0.52
Revenue
Revenue
₹70Cr
Rev Gr TTM
Revenue Growth TTM
4.16%
PAT Gr TTM
PAT Growth TTM
9.94%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
171716171818141718191716
Growth YoY
Revenue Growth YoY%
-0.92.02.2-3.56.65.4-9.8-2.0-0.52.119.8-1.9
Expenses
ExpensesCr
161715171717141617181616
Operating Profit
Operating ProfitCr
111011011111
OPM
OPM%
5.02.93.92.45.15.43.23.24.95.53.33.2
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
101011001110
Tax
TaxCr
000000000010
PAT
PATCr
101011001100
Growth YoY
PAT Growth YoY%
-8.3-56.3118.554.5-9.1166.7-44.129.44.075.0-87.94.5
NPM
NPM%
3.31.23.81.02.83.02.41.33.05.20.21.4
EPS
EPS₹
0.60.20.50.20.50.60.30.20.51.00.00.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
171716171818141718191716
Growth YoY
Revenue Growth YoY%
-0.92.02.2-3.56.65.4-9.8-2.0-0.52.119.8-1.9
Expenses
ExpensesCr
161715171717141617181616
Operating Profit
Operating ProfitCr
111011011111
OPM
OPM%
5.02.93.92.45.15.43.23.24.95.53.33.2
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
101011001110
Tax
TaxCr
000000000010
PAT
PATCr
101011001100
Growth YoY
PAT Growth YoY%
-8.3-56.3118.554.5-9.1166.7-44.129.44.075.0-87.94.5
NPM
NPM%
3.31.23.81.02.83.02.41.33.05.20.21.4
EPS
EPS₹
0.60.20.50.20.50.60.30.20.51.00.00.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
414349494859666567677070
Growth
Revenue Growth%
3.74.314.50.8-2.121.511.5-0.23.0-0.14.14.2
Expenses
ExpensesCr
384147474757636365646767
Operating Profit
Operating ProfitCr
322212322333
OPM
OPM%
7.04.35.04.23.03.74.43.83.44.14.34.3
Other Income
Other IncomeCr
010100000000
Interest Expense
Interest ExpenseCr
211100000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
101112222233
Tax
TaxCr
010001111111
PAT
PATCr
101111221222
Growth
PAT Growth%
30.0-182.6226.419.27.751.745.5-4.1-4.26.014.09.9
NPM
NPM%
1.3-1.01.11.41.51.92.42.32.22.32.52.5
EPS
EPS₹
0.8-0.60.80.91.01.52.01.61.51.61.82.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
414349494859666567677070
Growth
Revenue Growth%
3.74.314.50.8-2.121.511.5-0.23.0-0.14.14.2
Expenses
ExpensesCr
384147474757636365646767
Operating Profit
Operating ProfitCr
322212322333
OPM
OPM%
7.04.35.04.23.03.74.43.83.44.14.34.3
Other Income
Other IncomeCr
010100000000
Interest Expense
Interest ExpenseCr
211100000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
101112222233
Tax
TaxCr
010001111111
PAT
PATCr
101111221222
Growth
PAT Growth%
30.0-182.6226.419.27.751.745.5-4.1-4.26.014.09.9
NPM
NPM%
1.3-1.01.11.41.51.92.42.32.22.32.52.5
EPS
EPS₹
0.8-0.60.80.91.01.52.01.61.51.61.82.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
777778910101010
Reserves
ReservesCr
1220212222252730313234
Current Liabilities
Current LiabilitiesCr
2118151411131214111210
Non Current Liabilities
Non Current LiabilitiesCr
21111111122
Total Liabilities
Total LiabilitiesCr
4146454441474954525656
Current Assets
Current AssetsCr
3328212022312426222625
Non Current Assets
Non Current AssetsCr
918242419162629302931
Total Assets
Total AssetsCr
4146454441474954525656
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
777778910101010
Reserves
ReservesCr
1220212222252730313234
Current Liabilities
Current LiabilitiesCr
2118151411131214111210
Non Current Liabilities
Non Current LiabilitiesCr
21111111122
Total Liabilities
Total LiabilitiesCr
4146454441474954525656
Current Assets
Current AssetsCr
3328212022312426222625
Non Current Assets
Non Current AssetsCr
918242419162629302931
Total Assets
Total AssetsCr
4146454441474954525656

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-15146810116
Investing Cash Flow
Investing Cash FlowCr
0-1-100-6-51-10-1
Financing Cash Flow
Financing Cash FlowCr
-2-2-2-4-5111-10-1
Net Cash Flow
Net Cash FlowCr
-32-1-103-41-105
Free Cash Flow
Free Cash FlowCr
-1414670-1-105
CFO To PAT
CFO To PAT%
-265.4-1,106.4219.4559.2861.0694.859.714.552.161.4346.3
CFO To EBITDA
CFO To EBITDA%
-49.3265.450.0178.7426.1351.533.08.933.134.4203.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-15146810116
Investing Cash Flow
Investing Cash FlowCr
0-1-100-6-51-10-1
Financing Cash Flow
Financing Cash FlowCr
-2-2-2-4-5111-10-1
Net Cash Flow
Net Cash FlowCr
-32-1-103-41-105
Free Cash Flow
Free Cash FlowCr
-1414670-1-105
CFO To PAT
CFO To PAT%
-265.4-1,106.4219.4559.2861.0694.859.714.552.161.4346.3
CFO To EBITDA
CFO To EBITDA%
-49.3265.450.0178.7426.1351.533.08.933.134.4203.8

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
17222015825625055472936
Price To Earnings
Price To Earnings
32.436.323.211.523.139.133.038.030.616.719.3
Price To Sales
Price To Sales
0.40.50.40.30.20.40.90.80.80.70.40.5
Price To Book
Price To Book
0.91.31.10.50.41.12.31.31.71.40.81.0
EV To EBITDA
EV To EBITDA
9.516.111.49.95.56.320.119.323.616.27.69.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.932.234.339.938.731.935.842.241.542.345.545.5
OPM
OPM%
7.04.35.04.23.03.74.43.83.44.14.34.3
NPM
NPM%
1.3-1.01.11.41.51.92.42.32.22.32.52.5
ROCE
ROCE%
7.94.15.35.84.45.56.75.95.35.46.36.3
ROE
ROE%
2.9-1.62.02.32.53.44.43.93.63.74.04.0
ROA
ROA%
1.3-1.01.31.51.72.33.22.82.82.83.23.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
17222015825625055472936
Price To Earnings
Price To Earnings
32.436.323.211.523.139.133.038.030.616.719.3
Price To Sales
Price To Sales
0.40.50.40.30.20.40.90.80.80.70.40.5
Price To Book
Price To Book
0.91.31.10.50.41.12.31.31.71.40.81.0
EV To EBITDA
EV To EBITDA
9.516.111.49.95.56.320.119.323.616.27.69.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
44.932.234.339.938.731.935.842.241.542.345.545.5
OPM
OPM%
7.04.35.04.23.03.74.43.83.44.14.34.3
NPM
NPM%
1.3-1.01.11.41.51.92.42.32.22.32.52.5
ROCE
ROCE%
7.94.15.35.84.45.56.75.95.35.46.36.3
ROE
ROE%
2.9-1.62.02.32.53.44.43.93.63.74.04.0
ROA
ROA%
1.3-1.01.31.51.72.33.22.82.82.83.23.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Sandu Pharmaceuticals Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/7ysr8l2sbllx1hyqaxx2xckx.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/qaftnbcgt9y89izhqfkb0xc5.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/zfuqzss64u16r3ch4earoduo.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/5ae0bb6ssbxrqusfkjicj9i1.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/iy2mq76gwgayuo89wqtj5chr.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/xxgy69el67981xaah6iedmkf.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/2ktvot773z5uiz4la15hefha.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/57qk0pdfakgijbnicdf1qb4g.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/kwsu7ww7nmxsi0jfsv1ow7c2.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/pko9w41zvbuvojx3vo0z08st.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/93jwki5b8rrborbl56wdg89x.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/vrip2k6ugkv65ee5xb4cso7h.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/2bs1c1zntouglrv9upp5c3q0.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/vlw7yeh502c1mrso189c76vw.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/ctekybylt8xhk5cwgbpnduoz.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies